Connect with us

Technology

Tandem 2025: Roswell Park Team Creates Predictive Model to Inform Care of Lymphoma Patients

Published

on

In an invited talk at the upcoming Tandem meetings, Dr. Megan Herr of Roswell Park Comprehensive Cancer Center will highlight the link between patients’ physical function and CAR T outcomes; Dr. Shernan Holtan will be honored for contributions to combating graft-vs.-host disease, and other Roswell Park presentations will highlight the prospect for CAR T in breast cancer and ways to improve outcomes.

BUFFALO, N.Y. , Feb. 3, 2025 /PRNewswire-PRWeb/ — Discoveries made by experts from Roswell Park Comprehensive Cancer Center will be featured at an international conference focusing on the latest advances in stem cell transplantation and other cell therapies for blood cancers. The 2025 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) will be held Feb. 12-15 at the Hawai’i Convention Center in Honolulu, Hawaii. The annual meetings promote the exchange of information with the aim of extending patient survival and improving quality of life.

“We think this richer insight into a patient’s functioning and prognosis might point the way to strategies for supporting our patients with non-Hodgkin lymphoma, with the goal of improving outcomes following CAR T-cell therapy.” — Dr. Megan Herr

Oral abstract session highlights Roswell Park-developed scoring model

Megan Herr, PhD, Associate Professor of Oncology in the Department of Medicine, Transplant & Cellular Therapy section, led a research team that developed a scoring system to identify patients at risk of adverse outcomes following CAR T-cell therapy. She and her colleagues found that patients with non-Hodgkin lymphoma who had poor physical function prior to undergoing CAR T-cell therapy had an increased one-year mortality risk and a greater risk of developing a serious side effect called Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS).
“We developed a scoring system to predict which patients are most likely to develop serious side effects or adverse outcomes after receiving CAR T-cell therapy,” says Dr. Herr, who will highlight the findings in an invited talk on Feb. 14. “We think this richer insight into a patient’s functioning and prognosis might point the way to strategies for supporting our patients with non-Hodgkin lymphoma, with the goal of improving outcomes following CAR T-cell therapy.”

The work is outlined in Abstract 58, “Physical Function Measures Identify Non-Hodgkin Lymphoma Patients at High Risk of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) and 1-Year Mortality After Chimeric Antigen Receptor T (CAR T) Cell Therapy.” Dr. Herr is senior/presenting author of the research, to be presented Friday, Feb. 14, 4-4:15 p.m. HST in Ballroom A. Nisha Nair, MPH, Senior Research Specialist with Roswell Park’s Transplant & Cellular Therapy program, is first author of the study.

Dr. Holtan to receive 2025 Lukas D. Wartman Award

Shernan Holtan, MD, Professor of Medicine and Chief of Blood & Marrow Transplantation, will be honored during the conference with the 2025 Lukas D. Wartman Award, given in recognition of her groundbreaking work on the prevention and treatment of graft-versus-host disease (GVHD), a serious and sometimes life-threatening complication of blood stem cell or bone marrow transplant. The award recognizes a medical professional who has shown persistent dedication to improving outcomes for GVHD patients, served as their advocate, embraced new ideas to improve GVHD outcomes and advanced the science behind treating GVHD.

Dr. Holtan will take part in a Meet-the-Professor session where she will discuss how to leverage social media as a professional platform for networking, education, mentorship, advocacy, dissemination of scientific work and career advancement. That session, MTP-09, “How #Some (Social Media) Can Be an Asset for Hematologists and Oncologists,” will be held Friday, Feb. 14, 12:15-1:15 HST, in Room 309.

Dr. Betts chairs session of Immunobiology Working Committee

Brian Betts, MD, Professor of Oncology and Vice Chair of Strategic Initiatives in Transplant & Cellular Therapy, will chair a session of the CIBMTR Working Committee on Immunobiology. The committee provides oversight for studies related to histocompatibility and other genetic and immunologic issues related to hematopoietic cell transplantation. The session will be held Saturday, Feb. 15, 1-3 p.m. HST in Room 318 AB.

Additional research highlights

Several Roswell Park teams will present new findings and insights in a poster abstract session Thursday, Feb. 13, 6:45-7:45 p.m. HST in Exhibit Hall 3. Those featured research projects:

Marco Davila, MD, Senior Vice President and Associate Director for Translational Research and Rustum Family Endowed Chair in Translational Research, is first author and Dr. Betts is senior author on Abstract 340, “CD83 Expression by Human Breast Cancer Mediates Effective Killing by CAR T.”
Theresa Hahn, PhD, Professor of Oncology in the Department of Cancer Prevention and Control, is first author of Abstract 386, “Incidence of Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Is Not Lowered By Reduction of Acute GvHD (aGvHD) in Patients Receiving Post-Transplant Cyclophosphamide (PTCy) GvHD Prophylaxis: A report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium.”
Dr. Hahn is senior author of Abstract 193, “Pre-HCT Creatinine and Early Post-HCT Changes in Creatinine and Blood Pressure Associate with Severe Transplant-Associated Thrombotic Microangiopathy (TA-TMA): A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium.”
Matthew Cortese, MD, MPH, Assistant Professor of Oncology, Departments of Medicine and Cancer Genetics & Genomics, is first and presenting author on Abstract 303, “Clinical Outcomes of Transformed Marginal Zone Lymphoma and Richter Transformation with CAR T-Cell Therapy: A US Multicenter Real-World Analysis.”
Showkat Hamid, MD, Hematology/Oncology Fellow in the Department of Medicine, is presenting author of Abstract 330, “Dasatinib for Steroid Refractory Icans – a Single Center Experience.” Dr. Davila is senior author on the work.

From the world’s first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. Driven to eliminate cancer’s grip on humanity, the Roswell Park team of 4,000 makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Founded in 1898, Roswell Park was among the first three cancer centers nationwide to become a National Cancer Institute-designated comprehensive cancer center and is the only one to hold this designation in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit http://www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email ASKRoswell@RoswellPark.org.

Media Contact

Ann E Deck-Miller, Roswell Park Comprehensive Cancer Center, 716-845-8593, ann.deck-miller@roswellpark.org, roswellpark.org

View original content to download multimedia:https://www.prweb.com/releases/tandem-2025-roswell-park-team-creates-predictive-model-to-inform-care-of-lymphoma-patients-302366594.html

SOURCE Roswell Park Comprehensive Cancer Center

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Laifen Expands U.S. Retail Footprint with Costco Launch of Best-Selling SE Hair Dryer

Published

on

By

Starting July 18, Costco Members Can Shop Laifen’s Award-Winning Hair Dryer in Select Warehouse Locations Across the U.S.

NEW YORK, July 18, 2026 /PRNewswire/ — Laifen, ranked the world’s No.1 high-speed hair dryer brand, today announced the launch of its best-selling SE High-Speed Hair Dryer at select Costco warehouse locations, marking the brand’s largest U.S. retail expansion to date and bringing its award-winning haircare technology to Costco members across select U.S. markets.

The launch brings Laifen’s award-winning haircare technology to Costco, making it easier for consumers to experience the brand through one of the nation’s leading membership retailers. Laifen joins Costco’s growing portfolio of premium beauty and personal care brands. The initial rollout includes select Costco warehouse locations across the United States, with a strong presence across the Western U.S., including California, the Pacific Northwest and the Southwest.

Costco’s reputation for quality and its highly selective merchandising approach make this partnership especially meaningful. The Costco launch reflects Laifen’s continued expansion beyond direct-to-consumer channels as the brand accelerates its U.S. omnichannel retail strategy. “Costco represents an important milestone in our U.S. retail strategy,” said Romeo, General Manager of International Business of Laifen. “As more consumers seek salon-quality performance at an accessible price, we’re excited to make Laifen available through one of America’s most trusted retailers.”

Engineered to deliver professional-level performance in a sleek, lightweight design, the Laifen SE is powered by the brand’s proprietary high-speed brushless motor, delivering fast drying, reduced heat damage and smoother styling. An intelligent temperature control system continuously monitors airflow to help minimize frizz while protecting hair from excessive heat.

The Costco launch represents the next phase of Laifen’s U.S. retail expansion as the brand continues to grow beyond its direct-to-consumer and online channels. By expanding into one of the nation’s most trusted retailers, Laifen aims to broaden access to its category-disrupting haircare solutions while advancing its mission to bring more thoughtful design and everyday excellence into more homes.

The Laifen SE High-Speed Hair Dryer in White will be available at select Costco locations, while Costco.com shoppers will have access to additional color options including Purple and Pink, alongside the White model.

For more information on Laifen, please visit LaifenTech.com.

About Laifen: 

Founded in 2019, Laifen is a global personal care technology brand combining high-performance engineering with modern design across hair care, oral care, and grooming categories. Ranked the world’s No. 1 high-speed hair dryer brand by Euromonitor International, Laifen first gained recognition for its self-developed 110,000 RPM high-speed brushless motor, the proprietary technology behind its award-winning hair dryers.

Building on this innovation, Laifen has expanded its portfolio to include electric toothbrushes and shavers, delivering premium technology and elevated everyday experiences to consumers worldwide. Today, Laifen products and accessories are used by over 22 million households across more than 60 countries, supported by more than 600 patents and recognized with over 50 international design and innovation awards. Driven by continuous technological breakthroughs, Laifen is committed to making cutting-edge personal care technology more accessible to consumers around the world.

View original content to download multimedia:https://www.prnewswire.com/news-releases/laifen-expands-us-retail-footprint-with-costco-launch-of-best-selling-se-hair-dryer-302828573.html

SOURCE Laifen

Continue Reading

Technology

Pillsbury Notice of Data Breach

Published

on

By

NEW YORK, July 18, 2026 /PRNewswire/ — Pillsbury Winthrop Shaw Pittman LLP (“Pillsbury”) was among many law firms targeted by sophisticated social engineering attempts in an incident last year. While the firm quickly detected and blocked the activity, an unauthorized actor was able to access some of the firm’s documents during a short window of time. Pillsbury notified any impacted clients last year and undertook a detailed process to review the accessed documents for personal information. Pillsbury then began notifying individuals whose personal information was affected. That process is now complete, and today, Pillsbury is publishing substitute notice as a final step.

For more information, please visit the substitute notice on our website at https://www.pillsburylaw.com/en/breach-notice.html

View original content to download multimedia:https://www.prnewswire.com/news-releases/pillsbury-notice-of-data-breach-302828892.html

SOURCE Pillsbury Winthrop Shaw Pittman LLP

Continue Reading

Technology

From Remote Racing to Embodied AI: Fibocom and Intedigo Bring 5G Bidirectional Data Transmission into Real-World Applications

Published

on

By

SHANGHAI, July 18, 2026 /PRNewswire/ — From July 17 to 20, Fibocom and Intedigo will jointly present a cross-regional, beyond-visual-line-of-sight (BVLOS) teleoperation demonstration at Booth H3-C408 during the World Artificial Intelligence Conference (WAIC) 2026. Visitors will be able to enter a remote driving cockpit and control a real race car located at HURA PARK in Jiading, Shanghai, steering, accelerating, and braking in real time while experiencing how 5G connectivity enables remote operation.

More than an immersive driving experience, the demonstration provides a live validation of 5G bidirectional data transmission for embodied AI teleoperation. The vehicle continuously sends live track video, vehicle status, and operating data to the remote cockpit, while control commands are transmitted back to the vehicle, creating a closed-loop teleoperation system. Stable, low-latency, and highly reliable connectivity is essential for high-dynamic maneuvers such as high-speed cornering, precision braking, and continuous lane changes.

Developed by Intedigo, the remote driving system connects a real race car with an immersive remote driving cockpit. It supports 1080p@60Hz video transmission, glass-to-glass (G2G) video latency of less than 80 ms, and control latency of less than 10 ms. The demanding racing environment magnifies differences in video continuity and control responsiveness, making communications performance directly perceptible, measurable, and verifiable.

At the joint demonstration, Fibocom’s FM160 5G module provides cellular connectivity for the system. Powered by the Qualcomm Snapdragon™ X62 5G Modem-RF System, the FM160 supports SA and NSA network architectures as well as 3GPP Release 16. On the downlink, it supports NR Carrier Aggregation (NR CA) with bandwidth of up to 120 MHz, delivering peak speeds of up to 3.5 Gbps in NSA mode and 2.5 Gbps in SA mode. On the uplink, it supports UL MIMO and delivers peak speeds of up to 900 Mbps in SA mode. These capabilities support the continuous transmission of HD video and vehicle status data, along with reliable delivery of control commands.

As embodied AI moves into factories, data centers, logistics operations, and industrial parks, robots are becoming increasingly capable of performing tasks autonomously. Yet complex environments, unexpected events, and edge cases still require Human-in-the-Loop (HITL) remote intervention to help ensure safe and reliable operation.

Daniel Liu, CEO of Intedigo, said:

“5G represents the pinnacle of human communications and the starting point of machine communications. In the past, communications connected people to people; in the future, they will connect people to robots and robots to robots. Remote racing is simply the easiest entry point for people to understand this concept. What we are truly validating is a communications system capable of supporting remote collaboration for embodied AI. HURA makes low-latency remote driving a tangible experience, while RoBOX extends this capability to robots and a broader range of intelligent terminals. Together with Fibocom, we hope to enable more machines to receive remote assistance whenever needed while remaining continuously connected and operating reliably.”

Simon Tao, VP of Wireless Solutions Business Group and General Manager of MBB BU at Fibocom, said:

“As embodied AI enters real-world industrial environments, reliable connectivity will become the foundation for telemetry feedback, remote control and operational management. Fibocom’s 5G solutions, represented by FM160, provide the cellular connectivity required for continuous on-site data transmission and reliable control command delivery. Fibocom will continue collaborating with ecosystem partners such as Intedigo to bring cellular connectivity to more robots, autonomous machines and mobile intelligent terminals, enabling embodied AI systems to stay continuously connected and respond reliably in real-world applications.”

From remote race cars to robots, unmanned equipment, and mobile intelligent terminals, 5G is evolving from connecting people to connecting machines. This joint demonstration makes the capabilities of 5G bidirectional data transmission directly perceptible, experiential, and verifiable, helping pave the way for embodied AI to scale across real-world applications.
 

About Fibocom

Fibocom, founded in 1999, is China’s first wireless communication module company listed on both the A-share and H-share markets (300638.SZ, 0638.HK). As a global leading provider of wireless communication modules and AI solutions, Fibocom leverages wireless communication and artificial intelligence as its core technologies to provide integrated hardware and software solutions that empower industry applications. These solutions accelerate the transformation from “Connect Everything” to “Intelligent Connectivity” across diverse industries.

Fibocom’s one-stop solutions encompass cellular communication, AI, automotive, and GNSS modules, as well as AI toolchains, supporting industry-side and mainstream large model integration, and providing AI Agent, global connectivity, and cloud services, driving the digital intelligence upgrades in industries such as robotics, consumer electronics, low-altitude economy, intelligent transportation, smart retail, and smart energy.

View original content to download multimedia:https://www.prnewswire.com/news-releases/from-remote-racing-to-embodied-ai-fibocom-and-intedigo-bring-5g-bidirectional-data-transmission-into-real-world-applications-302828996.html

SOURCE Fibocom Wireless Inc.

Continue Reading

Trending